Table of Contents
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
 |
2 | Role of ZCCHC11 mutations in PMBL requires confirmation |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
| Entity | source | frequency (%) |
|---|---|---|
| BL | GAMBL Exome | 2.874 |
| BL | GAMBL Genome | 1.544 |
| DLBCL | GAMBL Exome | 2.21 |
| DLBCL | GAMBL Genome | 0.376 |
| FL | GAMBL Exome | 0.287 |
| MCL | GAMBL Genome | 1.17 |
Failed to render page: conflicting chdir during another chdir block
References
1.
Tiacci E, Ladewig E, Schiavoni G, Penson A,
Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S,
Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A,
Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C,
Pasqualucci L, Rabadan R, Falini B. Pervasive mutations of
JAK-STAT pathway genes in classical Hodgkin
lymphoma. Blood. 2018 May 31;131(22):2454–2465. PMCID: PMC6634958